[go: up one dir, main page]

ATE364402T1 - Stabile injizierbare diclofenac- zubereitungen - Google Patents

Stabile injizierbare diclofenac- zubereitungen

Info

Publication number
ATE364402T1
ATE364402T1 AT04257437T AT04257437T ATE364402T1 AT E364402 T1 ATE364402 T1 AT E364402T1 AT 04257437 T AT04257437 T AT 04257437T AT 04257437 T AT04257437 T AT 04257437T AT E364402 T1 ATE364402 T1 AT E364402T1
Authority
AT
Austria
Prior art keywords
diclofenac
cyclodextrin
salt
stable injectable
pharmaceutically acceptable
Prior art date
Application number
AT04257437T
Other languages
English (en)
Inventor
Lawrence John Penkler
Original Assignee
Shimoda Biotech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34826259&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE364402(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shimoda Biotech Pty Ltd filed Critical Shimoda Biotech Pty Ltd
Application granted granted Critical
Publication of ATE364402T1 publication Critical patent/ATE364402T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT04257437T 2004-03-10 2004-11-30 Stabile injizierbare diclofenac- zubereitungen ATE364402T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55135104P 2004-03-10 2004-03-10

Publications (1)

Publication Number Publication Date
ATE364402T1 true ATE364402T1 (de) 2007-07-15

Family

ID=34826259

Family Applications (2)

Application Number Title Priority Date Filing Date
AT07075004T ATE454905T1 (de) 2004-03-10 2004-11-30 Stabile injizierbare diclofenac- zubereitungen
AT04257437T ATE364402T1 (de) 2004-03-10 2004-11-30 Stabile injizierbare diclofenac- zubereitungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT07075004T ATE454905T1 (de) 2004-03-10 2004-11-30 Stabile injizierbare diclofenac- zubereitungen

Country Status (20)

Country Link
US (2) US20050238674A1 (de)
EP (2) EP1767219B1 (de)
JP (1) JP2007528384A (de)
KR (1) KR20070028331A (de)
AT (2) ATE454905T1 (de)
AU (1) AU2004317520B2 (de)
BR (1) BRPI0418474A (de)
CA (1) CA2555429C (de)
CY (1) CY1106824T1 (de)
DE (2) DE602004006952T2 (de)
DK (2) DK1574221T3 (de)
ES (2) ES2287658T3 (de)
HK (1) HK1079118A1 (de)
IL (1) IL177529A (de)
MX (1) MXPA06010336A (de)
PL (2) PL1767219T3 (de)
PT (2) PT1767219E (de)
SI (2) SI1767219T1 (de)
WO (2) WO2005092387A1 (de)
ZA (2) ZA200607631B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2888A (en) 2005-02-01 2014-05-31 Troikaa Pharmaceuticals Ltd Injectable preparations of diclofenic and its pharmaceutically acceptable salts
US20060205080A1 (en) * 2005-03-01 2006-09-14 David Frey Formulations for therapeutic viruses having enhanced storage stability
CA2647533A1 (en) * 2006-03-28 2007-10-04 Javelin Pharmaceuticals, Inc. Formulations of low dose non-steroidal anti-inflammatory drugs and beta-cyclodextrin
AU2012209035B9 (en) * 2006-03-28 2014-05-22 Javelin Pharmaceuticals, Inc. Formulations of low dose diclofenac and beta-cyclodextrin
KR20170123724A (ko) 2006-03-28 2017-11-08 자블린 파머슈티칼스 인코포레이티드 저 투여량의 디클로페낙 및 베타-사이클로덱스트린 제형
CL2007003877A1 (es) 2007-12-28 2008-06-27 Univ De Concepcion Lab Androma Composicion farmaceutica que comprende un complejo de inclusion formado por disulfiram y una ciclodextrina; y su uso para el tratamiento de la dependencia de alcohol y cocaina.
US20100022652A1 (en) * 2008-07-28 2010-01-28 Tyco Healthcare Group Lp Antimicrobial and Anticoagulant Compositions and Methods
AU2010224866C1 (en) 2009-03-16 2015-01-15 Genmedica Therapeutics Sl Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
US8466197B2 (en) 2010-12-14 2013-06-18 Genmedica Therapeutics Sl Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders
GB201021267D0 (en) 2010-12-15 2011-01-26 Reckitt Benckiser Healthcare Int Ltd Novel pharmaceutical formulation
ES2646226T3 (es) * 2011-07-20 2017-12-12 Hospira, Inc. Composiciones que comprenden diclofenaco para el tratamiento del dolor posoperatorio
WO2013020600A1 (en) * 2011-08-11 2013-02-14 Cross Sa Pharmaceutical composition comprising a drug containing at least one toxicophore function and n-acetyl-l-cysteine
KR101260636B1 (ko) 2012-11-29 2013-05-13 씨제이제일제당 (주) 안정화된 페메트렉시드 제제
US20140187635A1 (en) 2012-12-28 2014-07-03 Themis Medicare Limited Diclofenac compositions
US20140275261A1 (en) 2013-03-15 2014-09-18 Dr. Reddy's Laboratories, Inc. Diclofenac parenteral compositions
KR101485243B1 (ko) 2013-05-08 2015-01-21 씨제이헬스케어 주식회사 안정화된 페메트렉시드 제제
US11110073B2 (en) 2017-03-24 2021-09-07 Cadila Healthcare Limited Storage stable aqueous injectable solution comprising diclofenac
JP2020530462A (ja) * 2017-08-09 2020-10-22 ピードモント アニマル ヘルス インコーポレイテッド 治療製剤およびその使用
WO2021048748A1 (en) 2019-09-09 2021-03-18 Ftf Pharma Private Limited Pharmaceutical formulations comprising diclofenac
US11707443B2 (en) 2019-09-26 2023-07-25 Rk Pharma Inc. Storage stable aqueous parenteral solutions comprising diclofenac
CN110872942B (zh) * 2019-10-24 2021-09-28 中国石油化工股份有限公司 油藏注采耦合方式下不同作用力对采收率贡献的研究方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
US5690954A (en) * 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
US5389681A (en) * 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
IL111184A (en) * 1993-10-08 2000-08-13 Farmarc Nederland B V Of Cito Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin
ZA949182B (en) * 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
AU3609795A (en) * 1994-10-10 1996-05-02 Novartis Ag Ophthalmic and aural compositions containing diclofenac potassium
US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
AU5774796A (en) * 1995-06-13 1997-01-09 Dyer, Alison Margaret Pharmaceutical compositions containing lornoxicam and cyclod extrin
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
US6503481B1 (en) * 1999-05-03 2003-01-07 Battellepharma, Inc. Compositions for aerosolization and inhalation
ATE279920T1 (de) * 2000-12-28 2004-11-15 Fresenius Kabi Austria Gmbh Stabile infusionslösung von diclofenac-salzen, deren herstellung und verwendung
MXPA04007328A (es) * 2002-02-01 2005-07-05 Shimoda Biotech Pty Ltd Composicion farmaceutica.
TW200400055A (en) * 2002-02-22 2004-01-01 Pharmacia Corp Ophthalmic formulation with novel gum composition

Also Published As

Publication number Publication date
KR20070028331A (ko) 2007-03-12
AU2004317520B2 (en) 2011-06-09
SI1767219T1 (sl) 2010-03-31
BRPI0418474A (pt) 2007-06-19
ATE454905T1 (de) 2010-01-15
PL1574221T3 (pl) 2007-10-31
PT1767219E (pt) 2010-02-15
CA2555429C (en) 2010-05-18
DK1767219T3 (da) 2010-05-10
EP1767219A2 (de) 2007-03-28
PL1767219T3 (pl) 2010-06-30
EP1574221B1 (de) 2007-06-13
EP1574221A1 (de) 2005-09-14
WO2005086763A3 (en) 2006-03-02
DK1574221T3 (da) 2007-07-16
WO2005086763A2 (en) 2005-09-22
MXPA06010336A (es) 2007-02-16
JP2007528384A (ja) 2007-10-11
ZA200607631B (en) 2008-10-29
ES2287658T3 (es) 2007-12-16
WO2005092387A1 (en) 2005-10-06
DE602004006952T2 (de) 2008-02-14
US20050238674A1 (en) 2005-10-27
CY1106824T1 (el) 2012-05-23
EP1767219B1 (de) 2010-01-13
CA2555429A1 (en) 2005-10-06
IL177529A (en) 2013-08-29
ES2336034T3 (es) 2010-04-07
US20120142779A1 (en) 2012-06-07
IL177529A0 (en) 2006-12-10
SI1574221T1 (sl) 2007-10-31
PT1574221E (pt) 2007-07-09
HK1079118A1 (en) 2006-03-31
DE602004025151D1 (de) 2010-03-04
ZA200805860B (en) 2009-05-27
AU2004317520A1 (en) 2005-10-06
DE602004006952D1 (de) 2007-07-26
EP1767219A3 (de) 2007-04-25

Similar Documents

Publication Publication Date Title
HK1079118A1 (en) Stable injectable diclofenac compositions
JOP20200160A1 (ar) محاليل معلقة مائية للمركبات المسمى تي ام سي 278
NO20071914L (no) Kontrollert avleveringssystem
DK1881985T3 (da) Vandfrie krystalliske former af N-Y1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-D]pyrimidin-3-carbonyl¨methansulfonamid
CY1114892T1 (el) Φαρμακευτικη συνθεση ενος ισχυρου αναστολεα του hcv για απο του στοματος χορηγηση
ATE433988T1 (de) Phosphoramidatderivate
WO2009032034A3 (en) Stabilized picoplatin dosage form
WO2007075972A3 (en) Chlorite formulations, and methods of preparation and use thereof
UA89315C2 (en) Butylbenzene phthalein intravenous emulsion
BRPI0607649A2 (pt) prevenção de infecção por hiv
TW200603783A (en) Non-nucleoside reverse transcriptase inhibitors
ATE475408T1 (de) Formulierungen von tipifarnib zur intravenösen verabreichung
UA104420C2 (uk) Застосування похідних глутарової кислоти або їх фармацевтично прийнятних солей як протиаритмічних засобів
WO2011056630A3 (en) Small molecule inhibitors of hepatitis c virus
ATE526012T1 (de) Pharmazeutische formulierungen von meloxicam
TW200621160A (en) Anti-termite agent
ATE537822T1 (de) Antidepressivum
WO2008054767A3 (en) N4 modifications of pyrimidine analogs and uses thereof
TW200621785A (en) Analgesic
WO2008098077A3 (en) Substituted alkine derivatives as anti-cancer agents
WO2007121471A3 (en) Dialkyl ether delivery agents
WO2007143587A8 (en) Drug administration methods
EA200901085A1 (ru) Производные циклогексиламида арилкарбоновой кислоты
WO2007110811A3 (en) Use of the staudinger ligation in in vivo assembly of a biologically active compound
WO2009079679A3 (de) Pharmazeutische zusammensetzung zur parenteralen verabreichung eines ultrakurzwirksamξn beta-adrenorezeptor antagonisten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1574221

Country of ref document: EP